Stockreport

Verastem Oncology to Present Data on Two Lead Drug Candidates at ASCO 2018 Annual Meeting

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Results from the DUO™ crossover study with duvelisib demonstrate superior ORR and PFS compared to prior ofatumumab treatment and consistent with ORR in p [Read more]